Last day of the Roth conference. 30 biotech companies presenting including GALT, EPIX, CLRB. Learn more about what is happening in Dana Point and what you should be watching from Equities Research
The aluminum and primary metals supplier Alcoa (AA) opened the first quarter of 2013’s earnings report season with a mixed performance.Reporting after the close of the regular trading day on
Company chart and information is provided by TradingView based on 15-minute-delayed data.
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
Website: | www.essapharma.com |
Main Phone: | +1 778 331-0962 |
Address: | 999 West Broadway Street |
Address 2: | Suite 720 |
State: | BC |
City / Town: | Vancouver |
Country: | CA |
Postal Code: | V5Z 1K5 |
Exchange: | NSC |
CEO: | David R. Parkinson |
Employees: | 25 |
NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Last day of the Roth conference. 30 biotech companies presenting including GALT, EPIX, CLRB. Learn more about what is happening in Dana Point and what you should be watching from Equities Research
The aluminum and primary metals supplier Alcoa (AA) opened the first quarter of 2013’s earnings report season with a mixed performance.Reporting after the close of the regular trading day on
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |